A Randomized, Open Label, Active-controlled, Multiple Dosing and Crossover Clinical Trial to Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of YH4808 after Postprandial Oral Administration in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs YH 4808 (Primary) ; Esomeprazole
- Indications Gastro-oesophageal reflux; Peptic ulcer
- Focus Pharmacokinetics
- Sponsors Yuhan
- 14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Mar 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0000695).
- 23 Jan 2013 New trial record